Creative Biolabs-Immuno-oncology

Anti-ALK (clone ALK5L3) SynExpress C-Cy3-P-P Modified CD8+ T cells (CAT#: ITS-1224-CR969)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target ALK (clone ALK5L3). We employs the HBV (CMV-Cy3-PAX-PstI) vector components and the SynExpress system of the Exons Knock-in/Negative feedback for a robust and sustained response against cancers.
Host
Mouse
Target
ALK
Clone
ALK5L3
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
Cy3
Promoter
CMV
Effector Gene
PAX
Insertion Sites
PstI
Gene Modification
Knock-in
Modification Domain
Exons
Carrier Type
HBV
Transformation Accuracy
0.99
Cell Culture
Suspension Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.